Sponsor content
299 result(s) found, displaying 81 to 90
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
Cancellation by sponsorRequested by Abbvie Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Medicine administration kit, percutaneous, medicated, single-use.
-
Australian public assessment report (AusPar)AusPAR for RINVOQ (Upadacitinib) for treatment of atopic dermatitis in patients aged 12 years and above.
-
Australian public assessment report (AusPar)AusPAR for Maviret (glecaprevir /pibrentasvir) for the treatment of adult and paediatric patients with chronic hepatitis C virus.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RINVOQ upadacitinib 30 mg modified release tablet blister pack.